Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Language
Publication year range
1.
Nature ; 585(7825): 453-458, 2020 09.
Article in English | MEDLINE | ID: mdl-32908306

ABSTRACT

Heterochromatin that depends on histone H3 lysine 9 methylation (H3K9me) renders embedded genes transcriptionally silent1-3. In the fission yeast Schizosaccharomyces pombe, H3K9me heterochromatin can be transmitted through cell division provided the counteracting demethylase Epe1 is absent4,5. Heterochromatin heritability might allow wild-type cells under certain conditions to acquire epimutations, which could influence phenotype through unstable gene silencing rather than DNA change6,7. Here we show that heterochromatin-dependent epimutants resistant to caffeine arise in fission yeast grown with threshold levels of caffeine. Isolates with unstable resistance have distinct heterochromatin islands with reduced expression of embedded genes, including some whose mutation confers caffeine resistance. Forced heterochromatin formation at implicated loci confirms that resistance results from heterochromatin-mediated silencing. Our analyses reveal that epigenetic processes promote phenotypic plasticity, letting wild-type cells adapt to unfavourable environments without genetic alteration. In some isolates, subsequent or coincident gene-amplification events augment resistance. Caffeine affects two anti-silencing factors: Epe1 is downregulated, reducing its chromatin association, and a shortened isoform of Mst2 histone acetyltransferase is expressed. Thus, heterochromatin-dependent epimutation provides a bet-hedging strategy allowing cells to adapt transiently to insults while remaining genetically wild type. Isolates with unstable caffeine resistance show cross-resistance to antifungal agents, suggesting that related heterochromatin-dependent processes may contribute to resistance of plant and human fungal pathogens to such agents.


Subject(s)
Drug Resistance, Fungal/genetics , Gene Silencing , Heterochromatin/genetics , Heterochromatin/metabolism , Schizosaccharomyces/genetics , Caffeine/pharmacology , Drug Resistance, Fungal/drug effects , Gene Silencing/drug effects , Heterochromatin/drug effects , Histone Acetyltransferases/metabolism , Nuclear Proteins/metabolism , Phenotype , Schizosaccharomyces/cytology , Schizosaccharomyces/drug effects , Schizosaccharomyces/metabolism , Schizosaccharomyces pombe Proteins/metabolism
2.
Science ; 348(6230): 132-5, 2015 Apr 03.
Article in English | MEDLINE | ID: mdl-25838386

ABSTRACT

Posttranslational histone modifications are believed to allow the epigenetic transmission of distinct chromatin states, independently of associated DNA sequences. Histone H3 lysine 9 (H3K9) methylation is essential for heterochromatin formation; however, a demonstration of its epigenetic heritability is lacking. Fission yeast has a single H3K9 methyltransferase, Clr4, that directs all H3K9 methylation and heterochromatin. Using releasable tethered Clr4 reveals that an active process rapidly erases H3K9 methylation from tethering sites in wild-type cells. However, inactivation of the putative histone demethylase Epe1 allows H3K9 methylation and silent chromatin maintenance at the tethering site through many mitotic divisions, and transgenerationally through meiosis, after release of tethered Clr4. Thus, H3K9 methylation is a heritable epigenetic mark whose transmission is usually countered by its active removal, which prevents the unauthorized inheritance of heterochromatin.


Subject(s)
Cell Cycle Proteins/metabolism , Epigenesis, Genetic , Histones/metabolism , Lysine/metabolism , Methyltransferases/metabolism , Protein Processing, Post-Translational/genetics , Schizosaccharomyces pombe Proteins/metabolism , Schizosaccharomyces/enzymology , Schizosaccharomyces/genetics , Heterochromatin/metabolism , Histone-Lysine N-Methyltransferase , Methylation , Mutation , Nuclear Proteins/genetics , Schizosaccharomyces pombe Proteins/genetics
SELECTION OF CITATIONS
SEARCH DETAIL